Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Race Oncology Ltd. ( (AU:RAC) ) has provided an announcement.
Race Oncology Ltd announced the quotation of 1,295,909 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of October 9, 2025. This move is part of the company’s strategy to enhance its capital structure and potentially improve its market position, offering stakeholders an opportunity to engage with its growth trajectory.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, primarily focused on developing and commercializing cancer therapies. The company is known for its innovative approaches to oncology treatment and aims to address unmet medical needs in the cancer treatment market.
Average Trading Volume: 369,828
Technical Sentiment Signal: Buy
Current Market Cap: A$684.8M
Learn more about RAC stock on TipRanks’ Stock Analysis page.